These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10203106)

  • 1. Identification of a new candidate mutation, G1629R, in a family with type 2A von Willebrand disease.
    Casaña P; Martínez F; Haya S; Aznar JA
    Am J Hematol; 1999 Apr; 60(4):309-10. PubMed ID: 10203106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
    Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
    Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease family.
    Enayat MS; Guilliatt AM; Surdhar GK; Theophilus BD; Hill FG
    Thromb Haemost; 2000 Sep; 84(3):369-73. PubMed ID: 11019957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease.
    Gaucher C; Hanss M; Dechavanne M; Mazurier C
    Br J Haematol; 1993 Jan; 83(1):94-9. PubMed ID: 8435341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
    Wang Y; Zhang J; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
    Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
    Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand disease with G4022A mutation (vWd Sungnam): a case report.
    Song KS; Kang SH; Kang MS; Park YS; Choi JR; Kim HK; Park Q
    J Korean Med Sci; 1999 Feb; 14(1):93-6. PubMed ID: 10102532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
    Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
    Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
    Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
    Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
    Lethagen S; Isaksson C; Schaedel C; Holmberg L
    Thromb Haemost; 2002 Sep; 88(3):421-6. PubMed ID: 12353070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation (Leu817Pro) causing type 2A von Willebrand disease.
    Gemmati D; Serino ML; Moratelli S; Ballerini G; Furbetta M; Lunghi B; Marchetti G; Bernardi F
    Br J Haematol; 1996 Jan; 92(1):241-3. PubMed ID: 8562403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.